genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
One COVID-19 Shot, Two Approaches
Bioprocessing
Waters Opens Cambridge, MA, Collaboration Lab
Insights
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
News
Coronavirus
FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
Coronavirus
BARDA Balks at “Warp Speed” Funding for Oragenics COVID-19 Vaccine
Cancer
Researchers Keep Cancer Cells Out by Blocking the Gate to the…
Alzheimers
Alzheimer’s Epigenetic Drivers Identified
Coronavirus
Specific T Cells Activated in Severe COVID-19 Cases
Insights
All
Trends for 2020
Insights
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Insights
Cytiva Tests Filtration for Lentivirus Production
Insights
Observing the Performance of Planova Filters
Insights
Novel Tech Approaches for Analyzing Aggregation
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
Insights
Top 10 Earners among Women Biopharma Executives
Insights
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Insights
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Insights
Cytiva Tests Filtration for Lentivirus Production
Coronavirus
FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
Coronavirus
BARDA Balks at “Warp Speed” Funding for Oragenics COVID-19 Vaccine
Magazine
All
Supplement
Insights
Cold Cases Heat Up with New Forensic DNA Methods
Insights
CRISPR Value Chains Support New Therapeutic Strategies
Insights
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Insights
Insights
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Insights
Forces Unite to Move Molecular Dx Out of the Gates
Insights
Genome Editing Heads to Primetime
Insights
One-Stop-Shop Genome Editing Product Launched by Inscripta
Insights
Going Viral: The Next Generation of AAV Vectors
Insights
Genetics of Same-Sex Behavior Revealed
Insights
DNA Sequencing Accuracy Comes a Long Way
Insights
Eagle Genomics Soars into the Big Apple
Insights
Ginkgo Bioworks Co-Founder Honored with Rosalind Franklin Award
Insights
Gut Microbiome May Alter ALS Progression in Mice
Insights
MS Looks to Transcriptomics for Answers on Neuronal Vulnerability
Insights
CRISPR and LASER ART Eliminate HIV from Mice
Insights
Huntington’s Disease Therapy Uses the Power of Repression
Insights
Single Cell Writing May Unlock CRISPR’s Full Potential
Insights
Turning Drug Delivery Inside Out
Insights
Type 1 Diabetes Risk Lower in Infants with Rotavirus Vaccination
1
2
3
...
10
Page 1 of 10
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Firm had previously rejected Astellas’ unsolicited bid of roughly $3.5 billion. [© Yuri Arcurs - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/May17_2010_495175_HandshakeBirdsEyeView_AstellasBuysOSI7721122207-2.jpg "Forces Unite to Move Molecular Dx Out of the Gates")
